Clinical Trials Browser

Phase 1/2 × Terminated × Therapeutics × Clear all

NCT01892293 2019-01-10

CT Antigen TCR-Engineered T Cells for Myeloma

Phase 1/2 Terminated

6 enrolled 10 charts

Multiple Myeloma